Ipca Laboratories Limited
IPCALAB
Rankning i aktier
#3415
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures... Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, anti-hypertensive, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. The company also exports its products worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
Aktiekurs
$20.02
Senast synkroniserad: 2026-10-19
Marknadsvärde
$5.08B
Förändring (1 dag)
-1.65%
Förändring (1 år)
38.46%
Land
IN
Handel Ipca Laboratories Limited (IPCALAB)
Kategori
Healthcare
Antal utestående aktier för Ipca Laboratories Limited (IPCALAB)
Antal utestående aktier per June 2026: 253.70M
Enligt de senaste finansiella rapporterna och aktiekursen för Ipca Laboratories Limited är det aktuella antalet utestående aktier 253.70M. I slutet av March 2024 hade företaget 253.70M utestående aktier. Antalet utestående aktier påverkas vanligtvis av aktiesplit och återköp av aktier.
Historik över utestående aktier för Ipca Laboratories Limited (IPCALAB) från 2005 till 2026
Utestående aktier vid slutet av varje år
| År | Utestående aktier | Ändra |
|---|---|---|
| 2026 (TTM) | 253.70M | 0.00% |
| 2025 | 253.70M | 0.00% |
| 2024 | 253.70M | 0.00% |
| 2023 | 253.70M | 0.00% |
| 2022 | 253.70M | 0.17% |
| 2021 | 253.28M | 0.16% |
| 2020 | 252.89M | 0.09% |
| 2019 | 252.65M | 0.09% |
| 2018 | 252.42M | 0.01% |
| 2017 | 252.40M | -0.01% |
| 2016 | 252.41M | 0.01% |
| 2015 | 252.40M | 0.00% |
| 2014 | 252.40M | 0.03% |
| 2013 | 252.32M | 0.08% |
| 2012 | 252.11M | 0.52% |
| 2011 | 250.81M | 0.41% |
| 2010 | 249.79M | -0.51% |
| 2009 | 251.07M | 0.31% |
| 2008 | 250.31M | 0.12% |
| 2007 | 250.00M | 0.00% |
| 2006 | 250.00M | 0.00% |
| 2005 | 250.00M | 0.00% |
Utestående aktier för liknande företag eller konkurrenter
| Företag | Utestående aktier | Skillnad | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 845.72% |
IN
|
